RxDoctor Payments Data

James Williams, MD

Family Medicine · Williamston, SCNPI 1578756904

Payments from drug & device makers

$427in general payments, 2019–2025

Across 22 payments — averaging $19.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$129
  • AbbVie$43
  • Novo Nordisk$40
  • Dexcom, Inc.$36
  • Genmab U.S., Inc.$29
  • Mirati Therapeutics, Inc.$26
  • plus $124 from 6 others

What the payments were for

  • Food & beverage$427100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$427 in reported general payments places this provider in the 45th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$84,997
Medicare patients
200
Services billed
1,358

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide117$140,075
EliquisApixaban50$53,489
JardianceEmpagliflozin35$41,958
JanuviaSitagliptin Phosphate28$27,203
TrulicityDulaglutide26$26,610
XareltoRivaroxaban27$25,391
MounjaroTirzepatide15$15,267
SymbicortBudesonide/Formoterol Fumarate38$14,578
FarxigaDapagliflozin Propanediol14$14,393
Breo ElliptaFluticasone/Vilanterol23$13,811
LinzessLinaclotide13$9,978
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$9,573
Lantus SolostarInsulin Glargine,hum.Rec.Anlog46$6,209
Albuterol Sulfate HfaAlbuterol Sulfate180$6,186
Spiriva HandihalerTiotropium Bromide11$5,356

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$40$140,075117 claims
PfizerEliquis, Paxlovid$21$54,85763 claims
Lilly USA, LLCTrulicity, Mounjaro$129$41,87641 claims
AstraZenecaSymbicort, Farxiga$14$28,97152 claims
AbbVieLinzess$43$9,97813 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Williamston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →